☰

Nihar Kinarivala - Publications

Affiliations: 
 
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Leus IV, Adamiak J, Chandar B, Bonifay V, Zhao S, Walker SS, Squadroni B, Balibar CJ, Kinarivala N, Standke LC, Voss HU, Tan DS, Rybenkov VV, Zgurskaya HI. Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics. Antimicrobial Agents and Chemotherapy. e0137722. PMID 36715507 DOI: 10.1128/aac.01377-22  0.489
2021 Gardner TJ, Lee JP, Bourne CM, Wijewarnasuriya D, Kinarivala N, Kurtz KG, Corless BC, Dacek MM, Chang AY, Mo G, Nguyen KM, Brentjens RJ, Tan DS, Scheinberg DA. Engineering CAR-T cells to activate small-molecule drugs in situ. Nature Chemical Biology. PMID 34969970 DOI: 10.1038/s41589-021-00932-1  0.496
2021 Rahman MS, Kumari S, Hadi Esfahani S, Nozohouri S, Jayaraman S, Kinarivala N, Kocot J, Baez A, Farris D, Abbruscato TJ, Karamyan VT, Trippier PC. Correction to "Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability". Journal of Medicinal Chemistry. PMID 34935384 DOI: 10.1021/acs.jmedchem.1c02105  0.59
2021 Rahman MS, Kumari S, Esfahani SH, Nozohouri S, Jayaraman S, Kinarivala N, Kocot J, Baez A, Farris D, Abbruscato TJ, Karamyan VT, Trippier PC. Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability. Journal of Medicinal Chemistry. PMID 34436882 DOI: 10.1021/acs.jmedchem.1c00759  0.616
2020 Kinarivala N, Morsy A, Patel R, Carmona AV, Sajib MS, Raut S, Mikelis CM, Al-Ahmad A, Trippier PC. An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening. Acs Pharmacology & Translational Science. 3: 931-947. PMID 33073192 DOI: 10.1021/acsptsci.0c00077  0.647
2020 Sharma S, Singh A, Sharma S, Sharma R, Singh J, Kinarivala N, Nepali K, Liou JP. Tailored Quinolines Demonstrates Flexibility to Exert Antitumor Effects through Varied Mechanisms - A Medicinal Perspective. Anti-Cancer Agents in Medicinal Chemistry. PMID 32900354 DOI: 10.2174/1871520620666200908104303  0.358
2020 Maalouf K, Makoukji J, Saab S, Makhoul NJ, Carmona AV, Kinarivala N, Ghanem N, Trippier PC, Boustany RM. Exogenous Flupirtine as Potential Treatment for CLN3 Disease. Cells. 9. PMID 32796515 DOI: 10.3390/Cells9081872  0.643
2020 Kinarivala N, Standke LC, Guney T, Ji C, Noguchi N, Asano Y, Tan DS. Gram-scale preparation of the antibiotic lead compound salicyl-AMS, a potent inhibitor of bacterial salicylate adenylation enzymes. Methods in Enzymology. 638: 69-87. PMID 32416922 DOI: 10.1016/Bs.Mie.2020.04.051  0.546
2019 Singh H, Singh JV, Bhagat K, Gulati HK, Sanduja M, Kumar N, Kinarivala N, Sharma S. Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids. Bioorganic & Medicinal Chemistry. PMID 31255497 DOI: 10.1016/J.Bmc.2019.06.033  0.377
2019 Singh H, Kinarivala N, Sharma S. Multi-targeting Anticancer Agents: Rational Approaches, Synthetic Routes and Structure Activity Relationship. Anti-Cancer Agents in Medicinal Chemistry. PMID 30657048 DOI: 10.2174/1871520619666190118120708  0.337
2018 Makoukji J, Saadeh F, Mansour KA, El-Sitt S, Al Ali J, Kinarivala N, Trippier PC, Boustany RM. Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses. Annals of Clinical and Translational Neurology. 5: 1089-1103. PMID 30250865 DOI: 10.1002/Acn3.625  0.652
2017 Kinarivala N, Patel R, Boustany RM, Al-Ahmad AJ, Trippier PC. Discovery of Aromatic Carbamates that Confer Neuroprotective Activity by Enhancing Autophagy and Inducing the Anti-Apoptotic Protein B-cell lymphoma 2 (Bcl-2). Journal of Medicinal Chemistry. PMID 29110485 DOI: 10.1021/Acs.Jmedchem.7B01199  0.673
2017 Wang H, Huwaimel B, Verma K, Miller J, Germain T, Kinarivala N, Pappas D, Brookes P, Trippier PC. Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5. Chemmedchem. PMID 28523727 DOI: 10.1002/Cmdc.201700196  0.625
2016 Kinarivala N, Shah K, Abbruscato TJ, Trippier PC. Passage Variation of PC12 Cells Results in Inconsistent Susceptibility to Externally Induced Apoptosis. Acs Chemical Neuroscience. PMID 27718545 DOI: 10.1021/Acschemneuro.6B00208  0.632
2016 Kinarivala N, Suh JH, Botros M, Webb P, Trippier PC. Pharmacophore elucidation of phosphoiodyn A - Potent and selective peroxisome proliferator-activated receptor β/δ agonists with neuroprotective activity. Bioorganic & Medicinal Chemistry Letters. PMID 26988304 DOI: 10.1016/J.Bmcl.2016.03.028  0.639
2016 Kinarivala N, Trippier PC. Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs). Journal of Medicinal Chemistry. 59: 4415-27. PMID 26565590 DOI: 10.1021/Acs.Jmedchem.5B01020  0.648
2014 Kinarivala N, Trippier PC. Exploration of relative chemoselectivity in the hydrodechlorination of 2-chloropyridines Tetrahedron Letters. 55: 5386-5389. DOI: 10.1016/J.Tetlet.2014.08.008  0.577
Show low-probability matches.